Files
Download Full Text (1.7 MB)
Contents
- New Approaches Revolutionize the Treatment of Advanced Melanoma: Recent breakthroughs in immunotherapy and targeted therapy have improved outcomes for patients with advanced melanoma
- Comprehensive Tobacco Treatment Approach Helps Patients Quit on Their Terms: Kicking a tobacco habit is a formidable task. Quitting tobacco after a diagnosis of cancer, can be even more difficult
- Targeted Drug Shows Promise Against Advanced Breast Cancer: Adding the experimental kinase inhibitor palbociclib to standard hormonal therapy may delay disease progression in patients with advanced breast cancer that is estrogen receptor (ER) positive and human epidermal growth factor receptor 2 (HER@) negative
- HOUSE CALL: Avoiding Food-Drug Interactions: Some foods and medicines don’t mix
- INBRIEF: PKM2 Identified as Potential Prognostic Marker for Glioblastoma
Publication Date
2-1-2014
Publisher
The University of Texas MD Anderson Cancer Center
City
Houston, Texas
Keywords
Hwu, Patrick; Allison, James P.; Hwu, Wen-Jen; Lecagoonporn, Srisuda; Davis, Michael; Cinciripini, Paul; Rabius, Vance; Moulder, Stacy; Lu, Zhimin; Melanoma; Immunotherapy; Molecular Targeted Therapy; Tobacco Use Cessation; Counseling; Nicotine Replacement Therapy; Breast Neoplasms; Antineoplastic Agents; Food-Drug Interactions; Glioblastoma; Pyruvate Kinase.
Disciplines
History of Science, Technology, and Medicine | Oncology
Recommended Citation
Bronson, Sarah; Hale, Kathryn L.; Tutt, Bryan; and Yeoman, M., "OncoLog, Volume 59, Number 02, February 2014" (2014). OncoLog MD Anderson's Report to Physicians (All issues). 244.
https://openworks.mdanderson.org/oncolog/244
Conditions Governing Access
Open
